Work

First-in-human study of AMG 208, an oral MET inhibitor, in adult patients (pts) with advanced solid tumors.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.41

Authors: David S. Hong, Peter J. Rosen, A. Craig Lockhart, Siqing Fu, Filip Janku, Razelle Kurzrock, Rabia Khan, Benny Amore, Isaac Caudillo, Hongjie Deng, Yuying C. Hwang, Robert D. Loberg, Poornima Shubhakar, Stephen Zoog, Darrin M. Beaupre, Peter Lee

Institutions: The University of Texas MD Anderson Cancer Center, Tower Cancer Research Foundation, Washington University in St. Louis, Amgen (United States)

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589885830

Cites:

Cited by: 2

Related to: 10